Here is the latest shareholding Pattern of EVEXIA LIFECARE. For more details, see the EVEXIA LIFECARE financial fact sheet and EVEXIA LIFECARE share price. For a sector overview, read our energy sector report.
No. of Mths Qtr. Ending |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
3
Jun-24 |
3
Sep-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 10.59 | 9.87 | 9.87 | 9.87 | 9.87 | 9.26 | 6.29 | 5.87 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 10.59 | 9.87 | 9.87 | 9.87 | 9.87 | 9.26 | 6.29 | 5.87 | |
Mutual Funds | % | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.04 | 0.04 | |
Financial institution/Banks/Insurance | % | 0.23 | 0.21 | 0.21 | 0.21 | 0.21 | 0.20 | 0.13 | 0.13 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 6.79 | 3.36 | 3.36 | 1.43 | 0.00 | 1.03 | 1.49 | |
Other | % | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.01 | -0.00 | |
Total Institution | % | 0.30 | 7.07 | 3.64 | 3.64 | 1.71 | 0.26 | 1.21 | 1.66 | |
Bodies Corporate | % | 0.60 | 0.71 | 2.97 | 1.64 | 1.56 | 1.31 | 1.18 | 4.96 | |
Individuals | % | 85.89 | 78.47 | 79.59 | 82.07 | 83.98 | 81.52 | 83.36 | 56.63 | |
NRIs/OCBs | % | 1.22 | 1.94 | 1.42 | 1.62 | 1.45 | 1.35 | 0.90 | 1.01 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.40 | 1.94 | 2.51 | 1.16 | 1.43 | 6.30 | 7.06 | 29.87 | |
Total Non-Institution | % | 89.11 | 83.06 | 86.49 | 86.49 | 88.42 | 90.48 | 92.50 | 92.47 | |
Total Public | % | 89.00 | 90.00 | 90.00 | 90.00 | 90.00 | 91.00 | 94.00 | 94.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 15.35 | 15.35 | 15.35 | 15.35 | 15.35 | 15.35 | 15.35 | 0.00 | |
Subscriber Feature |
More Trading Company Shareholding Pattern: IOC RELIANCE IND. ONGC GAIL BPCL
On Tuesday, Indian share markets traded on a positive note throughout the session and ended marginally higher.